Brief: Akero Therapeutics To Be Acquired By Novo Nordisk For Up To $5.2 Billion
09/10/2025 11:19
Oct 9 (Reuters) - Akero Therapeutics Inc AKRO.O: AKERO THERAPEUTICS TO BE ACQUIRED BY NOVO NORDISK FOR UP TO $5.2 BILLION AKERO THERAPEUTICS INC - SHAREHOLDERS TO RECEIVE $54 PER SHARE IN CASH AKERO THERAPEUTICS INC - SHAREHOLDERS TO RECEIVE $54 PER SHARE IN CASH AND CVR OF $6 PER SHARE Source text: ID:nGNX5kN2lx Further company coverage: AKRO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akero Therapeutics
See all newsBrief: Novo Nordisk Completes Acquisition Of Akero Therapeutics
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Germany's Cartel Office Says It Approved Acquisition Of Akero Therapeutics By Novo Nordisk
Brief: Akero Therapeutics Stockholders Approve Acquisition By Novo Nordisk